Literature DB >> 19218022

Emergency treatment of status epilepticus: current thinking.

Dan Millikan1, Brian Rice, Robert Silbergleit.   

Abstract

Current thinking about the acute treatment of status epilepticus (SE) emphasizes a more aggressive clinical approach to this common life-threatening neurologic emergency. In this review, the authors consider four concepts that can accelerate effective treatment of SE. These include (1) updating the definition of SE to make it more clinically relevant, (2) consideration of faster ways to initiate first-line benzodiazepine therapy in the prehospital environment, (3) moving to second-line agents more quickly in refractory status in the emergency department, and (4) increasing detection and treatment of unrecognized nonconvulsive SE in comatose neurologic emergency patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218022     DOI: 10.1016/j.emc.2008.12.001

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  8 in total

Review 1.  Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus.

Authors:  Karthik Rajasekaran; Santina A Zanelli; Howard P Goodkin
Journal:  Semin Pediatr Neurol       Date:  2010-09       Impact factor: 1.636

2.  Status epilepticus.

Authors:  Panayiotis N Varelas; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

Review 3.  Status epilepticus: an update.

Authors:  Panayiotis N Varelas; Marianna V Spanaki; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

4.  Intramuscular versus intravenous therapy for prehospital status epilepticus.

Authors:  Robert Silbergleit; Valerie Durkalski; Daniel Lowenstein; Robin Conwit; Arthur Pancioli; Yuko Palesch; William Barsan
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

5.  Intranasal midazolam compared with intravenous diazepam in patients suffering from acute seizure: a randomized clinical trial.

Authors:  Mohsen Javadzadeh; Kourosh Sheibani; Mozhgan Hashemieh; Hedyeh Saneifard
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

6.  Sesamin ameliorates oxidative stress and mortality in kainic acid-induced status epilepticus by inhibition of MAPK and COX-2 activation.

Authors:  Peiyuan F Hsieh; Chien-Wei Hou; Pei-Wun Yao; Szu-Pei Wu; Yu-Fen Peng; Mei-Lin Shen; Ching-Huei Lin; Ya-Yun Chao; Ming-Hong Chang; Kee-Ching Jeng
Journal:  J Neuroinflammation       Date:  2011-05-24       Impact factor: 8.322

7.  Propofol effectively inhibits lithium-pilocarpine- induced status epilepticus in rats via downregulation of N-methyl-D-aspartate receptor 2B subunit expression.

Authors:  Henglin Wang; Zhuoqiang Wang; Weidong Mi; Cong Zhao; Yanqin Liu; Yongan Wang; Haipeng Sun
Journal:  Neural Regen Res       Date:  2012-04-15       Impact factor: 5.135

8.  Treatment of status epilepticus in pediatrics: curriculum learning combined with in-situ simulations.

Authors:  Huiping Wei; Hui Zhao; Ziming Huang; Xinyun Lei; Ming He; Ran Dong; Jiannan Wu; Jing Yue
Journal:  BMC Med Educ       Date:  2022-07-19       Impact factor: 3.263

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.